Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS
Title:
Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS
Author:
Fu, Weijun Li, Wei Hu, Jianda An, Gang Wang, Yafei Fu, Chengcheng Chen, Lijuan Jin, Jie Cen, Xinan Ge, Zheng Cai, Zhen Niu, Ting Qi, Ming Gai, Xue Li, Qian Liu, Weiping Liu, Wenyu Yang, Xue Chen, Xi Lu, Jin